11 Jul 2019
AbbVie Acquires Allergan for long-term
By Staff Writer
Following the news that AbbVie has acquired Allergan for $63bn, Maura Musciacco, MSc, senior director of Neurology & Ophthalmology at GlobalData, a leading data and analytics company, offers her view on this mega-merger: ‘The combined AbbVie-Allergan company is expected to be catapulted to fifth position in terms of 2019 sales, overtaking many competing pharma companies....
